Table 5 Parameters explaining silent myocardial ischemia and coronary artery disease in multivariate analyses
| Â | Odds ratio | 95Â % confidence interval | p |
|---|---|---|---|
Silent myocardial ischemia in patients with LDL <3.35 mmol/L: H Lemershow: 7.35, p = 0.499 | |||
 Male gender | 2.1 | 1.5–2.9 | <0.001 |
 Body mass index | 0.97 | 0.94–0.997 | <0.05 |
 Retinopathy | 1.4 | 1.1–1.9 | <0.05 |
 Peripheral occlusive arterial disease | 2.5 | 1.6–3.8 | <0.001 |
 Mean blood pressure | 1.01 | 1.00–1.03 | 0.01 |
 Atherogenic dyslipidemia | 1.8 | 1.0–3.3 | 0.05 |
 Smoking |  |  | NS |
Silent coronary artery disease in patients with LDL <3.35 mmol/L: H Lemershow: 5.30, p = 0.725 | |||
 Male gender | 3.0 | 1.6–5.6 | <0.0001 |
 Body mass index | 0.94 | 0.90–0.995 | <0.05 |
 Retinopathy | 1.7 | 1.0–2.9 | <0.05 |
 Microalbuminuria |  |  | NS |
 Peripheral occlusive arterial disease | 4.0 | 2.1–7.4 | <0.0001 |
 Mean blood pressure | 1.03 | 1.01–1.05 | 0.001 |
 Atherogenic dyslipidemia | 4.0 | 1.7–9.2 | 0.001 |
 Smoking |  |  | NS |
Silent coronary artery disease in patients with LDL <2.6 mmol/L: H Lemershow: 12.85, p = 0.117 | |||
 Male gender | 3.0 | 1.1–8.2 | <0.05 |
 Body mass index |  |  | 0.07 |
 Retinopathy |  |  | 0.09 |
 Peripheral occlusive arterial disease | 3.7 | 1.7–8.1 | 0.001 |
 Mean blood pressure | 1.03 | 1.00–1.06 | <0.05 |
 Atherogenic dyslipidemia | 2.96 | 0.97–9.03 | 0.057 |
 Smoking | 2.2 | 1.1–4.4 | <0.05 |